WHO ICTRP trial
Pregabalin tablet for Postoperative pain in breast suregry patients
CTRI/2022/12/048101 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/12/048101 |
|---|---|
| Public title | Pregabalin tablet for Postoperative pain in breast suregry patients |
| Scientific title | Comparison of two doses of pregabalin as Pre-emptive analgesic in reducing postoperative pain in patients undergoing breast surgery. |
| Primary sponsor | Dr. Pooja K Subbiah |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: O- Medical and Surgical |
| Interventions | Intervention1: Capsule Pegabalin 75 mg: Capsule Pregabalin 75mg will be given to Group A two hours prior to surgery. Intervention2: Capsule Pregabalin 150mg: Capsule Pregabalin 150 mg will be given to Group B two hours prior to surgery… |
| Registration date | Dec 14, 2022 |
| Target size | 86 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: